In addition, skeletal muscle loss often leads to increased intramuscular fat infiltration, which in turn leads to insulin resistance, muscle strength loss and motor dysfunction, which can lead to systolic dysfunction and metabolic and endocrine abnormalities, and ultimately lead to cancer cachexia (44). The gene discussed is INS; the disease is Cachexia.